company

NORSE BIO AS

7014 TRONDHEIM

Return on Equity
310 %
Current Ratio
0,62
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue1 000
Net Income−31 000
Total Assets16 000
Total Equity−10 000
Income (NOK)2022
Revenue1 000
Expenditure21 000
Operating Profit−20 000
Financial Income0
Financial Costs5 000
Financial Balance−5 000
Earnings Before Tax−25 000
Tax6 000
Net Income−31 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets16 000
Total Assets16 000
Total Retained Equity−31 000
Total Equity−10 000
Total Long-Term Debt0
Total Current Debt26 000
Total Equity and Debt16 000
Cash flow (NOK)2022
Sales Income1 000
Other Income0
Revenue1 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure21 000
Operating Profit−20 000
Financial Income0
Financial Costs5 000
Financial Balance−5 000
Dividends0
Net Income−31 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank16 000
Total Current Assets16 000
Total Assets16 000
Total Equity−10 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors4 000
Unpaid Taxes−3 000
Dividends0
Other Current Debt0
Total Current Debt26 000
Total Equity and Debt16 000
Financial indicators2022
Return on Equity310 %
Debt-to-Equity Ratio−0
Operating Profit Margin−2 000 %
Current Ratio0,62
Quick Ratio0,62
Equity Ratio−0,63
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English